Showing results (1-10 of 284) with videos related to
Sort By:
Pageof 29
ACS Medicinal Chemistry Letters|June 18, 2025
Deuterated 1,3 Dihydro‑2H‑indole-2-one Derivatives for Treatment of Depression or AnxietyQi-Long Hu, Steven H LiangACS Medicinal Chemistry Letters|March 19, 2025
Novel Cyclic Peptides Inhibiting Tumor Necrosis Factor Receptor 1 ActivityQi-Long Hu, Steven H LiangACS Medicinal Chemistry Letters|February 19, 2025
Cyclic Peptides Targeting Granzyme B: Potential Applications as PET Imaging AgentsQi-Long Hu, Steven H LiangACS Medicinal Chemistry Letters|April 16, 2025
Novel Cyclic Peptides as Interleukin-23 Inhibitor for Treating Inflammatory DisordersQi-Long Hu, Steven H LiangACS Medicinal Chemistry Letters|November 19, 2025
Novel Bicyclic Peptides Targeting Interleukin-23 Receptor to Relieve Inflammatory ConditionsQi-Long Hu, Steven H LiangACS Medicinal Chemistry Letters|July 16, 2025
Novel Heterocyclic 5H‑Dibenzo[b,f]azepine Derivatives as Selective HDAC6 Inhibitors for Treatment of Charcot Marie Tooth DiseaseSteven H LiangAmerican Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
PARP-targeted molecular imaging for noninvasive diagnosis and surgical guidance in basal cell carcinomaSteven H LiangAmerican Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
From lutetium to terbium: a new era in PSMA-targeted radioligand therapy for mCRPC patientsSteven H LiangAmerican Journal of Nuclear Medicine and Molecular Imaging|July 24, 2026
ACP3-targeted PET imaging agents based on small-molecule ligands for prostate cancer diagnostics and theranosticsSteven H LiangAmerican Journal of Nuclear Medicine and Molecular Imaging|July 24, 2026
Is FAP the key to unlocking treatment for rare soft-tissue sarcomas?Steven H LiangPageof 29